Clinical Trial Update: The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update on dolutegravir antiretroviral mono-therapy for HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED